Effect of oxygen therapy duration on cognitive impairment 12 months after hospitalization for SARS-COV-2 infection
Journal of Rehabilitation Medicine · 2023
DOI: 10.2340/jrm.v55.12609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Rehabilitation Medicine, 2023. Verfasst von Amandine Rapin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical and Rehabilitation Medicine, hôpital Sebastopol, Reims, France; Faculty of Medicine, Reims Champagne-Ardenne University, MATIM…. Hauptthemen laut MEDLINE: COVID-19, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To identify predictors of persistent cognitive impairment at 12 months after hospitalization due to COVID-19 (SARS-CoV-2) infection.
Design
Retrospective, single-centre study. Subjects: All consecutive patients assessed in physical and rehabilitation medicine consultations at 3 months with a neuropsychiatric testing (NPT) at 6 months.
Methods
A Mini Mental State Examination (MMSE) was performed at 3 months and NPT at 6 and 12 months, exploring global cognitive efficiency, attention and processing speed, short-term memory and executive function. Logistic regression and receiver operating characteristic curves were used to identify predictors of persistent cognitive impairment.
Results
Among 56 patients, 64.3% and 53.6% had 1 or more impaired cognitive functions at 6 and 12 months, respectively, attention and processing speed being the most represented (41.1% at 12 month). Duration of oxygen therapy (odds ratio 0.926 [0.871–0.985], p = 0.015) and MMSE score at 3 months (odds ratio 0.464 [0.276–0.783], p = 0.004) were associated with cognitive impairment at 12 months by multivariable analysis (R² 0.372–0.497).
Conclusions
Half of patients have cognitive impairment 12 months after acute SARS-CoV-2 infection requiring hospitalization. The duration of oxygen therapy in acute care could be a protective parameter. Systematic evaluation with the MMSE at 3 months after infection might be an effective tool to detect risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physical and Rehabilitation Medicine, hôpital Sebastopol, Reims, France; Faculty of Medicine, Reims Champagne-Ardenne University, MATIM, Reims, France VieFra, EA3797, Reims, France. arapin@chu-reims.fr.
- Department of Physical and Rehabilitation Medicine, hôpital Sebastopol, Reims, France; Reims Champagne-Ardenne University, C2S, EA6291, Reims, France.
- Physical and Rehabilitation Medicine department, Strasbourg University Hospital, Strasbourg, France.
- Reims Champagne-Ardenne University, MATIM, Reims, France.
- Department of Physical and Rehabilitation Medicine, hôpital Sebastopol, Reims, France.
- Functional neuroscience and pathologies laboratory (UR UPJV 4559), Amiens University Hospital , Amiens, France.
Zitieren
APA
Rapin, A., Calmus, A., Pradeau, C., Taiar, R., Belassian, G., Godefroy, O., Carazo-Mendez, S., & Boyer, F. C. (2023). Effect of oxygen therapy duration on cognitive impairment 12 months after hospitalization for SARS-COV-2 infection. Journal of Rehabilitation Medicine. https://doi.org/10.2340/jrm.v55.12609
Vancouver
Rapin A, Calmus A, Pradeau C, Taiar R, Belassian G, Godefroy O, et al. Effect of oxygen therapy duration on cognitive impairment 12 months after hospitalization for SARS-COV-2 infection. Journal of Rehabilitation Medicine. 2023. doi:10.2340/jrm.v55.12609
BibTeX
@article{Rapin2023,
author = {Rapin, Amandine and Calmus, Arnaud and Pradeau, Charles and Taiar, Redha and Belassian, Gaël and Godefroy, Olivier and Carazo-Mendez, Sandy and Boyer, Francois C},
title = {Effect of oxygen therapy duration on cognitive impairment 12 months after hospitalization for SARS-COV-2 infection},
journal = {Journal of Rehabilitation Medicine},
year = {2023},
doi = {10.2340/jrm.v55.12609}
}
EUVIMED